Epidemiology and diagnosis of Lyme borreliosis

References

• Stanek G., Strle F. Lyme borreliosis. Lancet 2003; 362: 1639–47
   PubMed Web of Science ®Google Scholar
• Steere A. C. Lyme disease. N Engl J Med 1989; 321: 586–96
   PubMed Web of Science ®Google Scholar
• Pfister H. W., Wilske B., Weber K. Lyme borreliosis: basic science and clinical aspects. Lancet 1994; 343: 1013–6
   PubMed Web of Science ®Google Scholar
• Burgdorfer W., Barbour A. G., Hayes S. F., Benach J. L., Grunwaldt E., Davis J. P. Lyme disease‐a tick‐borne spirochetosis?. Science 1982; 216: 1317–9
   PubMed Web of Science ®Google Scholar
• Berglund J., Eitrem R., Ornstein K., Lindberg A., Ringer A., Elmrud H., et al. An epidemiologic study of Lyme disease in southern Sweden. N Engl J Med 1995; 333: 1319–27
   PubMed Web of Science ®Google Scholar
• Strle F. Lyme borreliosis in Slovenia. Zentralbl Bakteriol 1999; 289: 643–52
   PubMedGoogle Scholar
• Wilske B., Steinhuber R., Bergmeister H., Fingerle V., Schierz G., Preac‐Mursic V., et al. [Lyme borreliosis in South Germany. Epidemiologic data on the incidence of cases and on the epidemiology of ticks (Ixodes ricinus) carrying Borrelia burgdorferi]. Dtsch Med Wochenschr 1987; 112: 1730–6
   PubMedGoogle Scholar
• Asbrink E., Hovmark A., Hederstedt B. The spirochetal etiology of acrodermatitis chronica atrophicans Herxheimer. Acta Derm Venereol 1984; 64: 506–12
   PubMed Web of Science ®Google Scholar
• Schmidt R., Kabatzki J., Hartung S., Ackermann R. [Erythema migrans borreliosis in the Federal Republic of Germany. Epidemiology and clinical aspects]. Dtsch Med Wochenschr 1985; 110: 1803–7
   PubMed Web of Science ®Google Scholar
• Wang G., van Dam A. P., Schwartz I., Dankert J. Molecular typing of Borrelia burgdorferi sensu lato: taxonomic, epidemiological, and clinical implications. Clin Microbiol Rev 1999; 12: 633–53
   PubMed Web of Science ®Google Scholar
• Wilske B., Preac‐Mursic V., Göbel U. B., Graf B., Jauris S., Soutschek E., et al. An OspA serotyping system for Borrelia burgdorferi based on reactivity with monoclonal antibodies and OspA sequence analysis. J Clin Microbiol 1993; 31: 340–50
   PubMed Web of Science ®Google Scholar
• Canica M. M., Nato F., du M. L., Mazie J. C., Baranton G., Postic D. Monoclonal antibodies for identification of Borrelia afzelii sp. nov. associated with late cutaneous manifestations of Lyme borreliosis. Scand J Infect Dis 1993; 25: 441–8
   PubMed Web of Science ®Google Scholar
• Ohlenbusch A., Matuschka F. R., Richter D., Christen H. J., Thomssen R., Spielman A., et al. Etiology of the acrodermatitis chronica atrophicans lesion in Lyme disease. J Infect Dis 1996; 174: 421–3
   PubMed Web of Science ®Google Scholar
• Eiffert H., Ohlenbusch A., Christen H. J., Thomssen R., Spielman A., Matuschka F. R. Nondifferentiation between Lyme disease spirochetes from vector ticks and human cerebrospinal fluid. J Infect Dis 1995; 171: 476–9
   PubMed Web of Science ®Google Scholar
• van Dam A. P., Kuiper H., Vos K., Widjojokusumo A., de Jongh B. M., Spanjaard L., et al. Different genospecies of Borrelia burgdorferi are associated with distinct clinical manifestations of Lyme borreliosis. Clin Infect Dis 1993; 17: 708–17
   PubMed Web of Science ®Google Scholar
• Wilske B., Busch U., Eiffert H., Fingerle V., Pfister H. W., Rössler D., et al. Diversity of OspA and OspC among cerebrospinal fluid isolates of Borrelia burgdorferi sensu lato from patients with neuroborreliosis in Germany. Med Microbiol Immunol (Berl) 1996; 184: 195–201
   PubMed Web of Science ®Google Scholar
• Eiffert H., Karsten A., Thomssen R., Christen H. J. Characterization of Borrelia burgdorferi strains in Lyme arthritis. Scand J Infect Dis 1998; 30: 265–8
   PubMedGoogle Scholar
• Vasiliu V., Herzer P., Rössler D., Lehnert G., Wilske B. Heterogeneity of Borrelia burgdorferi sensu lato demonstrated by an ospA‐type‐specific PCR in synovial fluid from patients with Lyme arthritis. Med Microbiol Immunol (Berl) 1998; 187: 97–102
   PubMed Web of Science ®Google Scholar
• Jaulhac B., Chary‐Valckenaere I., Sibilia J., Javier R. M., Piemont Y., Kuntz J. L., et al. Detection of Borrelia burgdorferi by DNA amplification in synovial tissue samples from patients with Lyme arthritis. Arthritis Rheum 1996; 39: 736–45
   PubMed Web of Science ®Google Scholar
• Jaulhac B., Heller R., Limbach F. X., Hansmann Y., Lipsker D., Monteil H., et al. Direct molecular typing of Borrelia burgdorferi sensu lato species in synovial samples from patients with lyme arthritis. J Clin Microbiol 2000; 38: 1895–900
   PubMed Web of Science ®Google Scholar
• Lunemann J. D., Zarmas S., Priem S., Franz J., Zschenderlein R., Aberer E., et al. Rapid typing of Borrelia burgdorferi sensu lato species in specimens from patients with different manifestations of Lyme borreliosis. J Clin Microbiol 2001; 39: 1130–3
   PubMed Web of Science ®Google Scholar
• Hubalek Z., Halouzka J. Distribution of Borrelia burgdorferi sensu lato genomic groups in Europe, a review. Eur J Epidemiol 1997; 13: 951–7
   PubMed Web of Science ®Google Scholar
• Gern L., Hu C. M., Kocianova E., Vyrostekova V., Rehacek J. Genetic diversity of Borrelia burgdorferi sensu lato isolates obtained from Ixodes ricinus ticks collected in Slovakia. Eur J Epidemiol 1999; 15: 665–9
   PubMed Web of Science ®Google Scholar
• Michel H., Wilske B., Hettche G., Goettner G., Heimerl C., Reischl U., et al. An ospA‐polymerase chain reaction/restriction fragment length polymorphism‐based method for sensitive detection and reliable differentiation of all European Borrelia burgdorferi sensu lato species and OspA types. Med Microbiol Immunol (Berl) 2003; 193: 219–26
   PubMed Web of Science ®Google Scholar
• Rauter C., Oehme R., Diterich I., Engele M., Hartung T. Distribution of clinically relevant Borrelia genospecies in ticks assessed by a novel, single‐run, real‐time PCR. J Clin Microbiol 2002; 40: 36–43
   PubMed Web of Science ®Google Scholar
• Rijpkema S., Golubic D., Molkenboer M., Verbeek‐de Kruif N., Schellekens J. Identification of four genomic groups of Borrelia burgdorferi sensu lato in Ixodes ricinus ticks collected in a Lyme borreliosis endemic region of northern Croatia. Exp Appl Acarol 1996; 20: 23–30
   PubMed Web of Science ®Google Scholar
• Peter O., Bretz A. G., Bee D. Occurrence of different genospecies of Borrelia burgdorferi sensu lato in ixodid ticks of Valais, Switzerland. Eur J Epidemiol 1995; 11: 463–7
   PubMed Web of Science ®Google Scholar
• Demaerschalck I., Ben Messaoud A., De Kesel M., Hoyois B., Lobet Y., Hoet P., et al. Simultaneous presence of different Borrelia burgdorferi genospecies in biological fluids of Lyme disease patients. J Clin Microbiol 1995; 33: 602–8
   PubMed Web of Science ®Google Scholar
• Ruzic‐Sabljic E., Arnez M., Logar M., Maraspin V., Lotric‐Furlan S., Cimperman J., et al. Comparison of Borrelia burgdorferi Sensu Lato Strains Isolated from Specimens Obtained Simultaneously from Two Different Sites of Infection in Individual Patients. J Clin Microbiol 2005; 43: 2194–200
   PubMed Web of Science ®Google Scholar
• Olsen B., Duffy D. C., Jaenson T. G., Gylfe A., Bonnedahl J., Bergstrom S. Transhemispheric exchange of Lyme disease spirochetes by seabirds. J Clin Microbiol 1995; 33: 3270–4
   PubMed Web of Science ®Google Scholar
• Humair P., Gern L. The wild hidden face of Lyme borreliosis in Europe. Microbes Infect 2000; 2: 915–22
   PubMed Web of Science ®Google Scholar
• Kurtenbach K., Sewell H. S., Ogden N. H., Randolph S. E., Nuttall P. A. Serum complement sensitivity as a key factor in Lyme disease ecology. Infect Immun 1998; 66: 1248–51
   PubMed Web of Science ®Google Scholar
• Kraiczy P., Skerka C., Kirschfink M., Zipfel P. F., Brade V. Mechanism of complement resistance of pathogenic Borrelia burgdorferi isolates. Int Immunopharmacol 2001; 1: 393–401
   PubMed Web of Science ®Google Scholar
• Fingerle V., Liegl G., Munderloh U., Wilske B. Expression of outer surface proteins A and C of Borrelia burgdorferi in Ixodes ricinus ticks removed from humans. Med Microbiol Immunol (Berl) 1998; 187: 121–6
   PubMed Web of Science ®Google Scholar
• Schwan T. G., Piesman J., Golde W. T., Dolan M. C., Rosa P. A. Induction of an outer surface protein on Borrelia burgdorferi during tick feeding. Proc Natl Acad Sci U S A 1995; 92: 2909–13
   PubMed Web of Science ®Google Scholar
• de Silva A. M., Fikrig E. Growth and migration of Borrelia burgdorferi in Ixodes ticks during blood feeding. Am J Trop Med Hyg 1995; 53: 397–404
   PubMed Web of Science ®Google Scholar
• Kahl O., Janetzki‐Mittmann C., Gray J. S., Jonas R., Stein J., de Boer R. Risk of infection with Borrelia burgdorferi sensu lato for a host in relation to the duration of nymphal Ixodes ricinus feeding and the method of tick removal. Zentralbl Bakteriol 1998; 287: 41–52
   PubMedGoogle Scholar
• Rijpkema S. G., Tazelaar D. J., Molkenboer M. J., Noordhoek G. T., Plantinga G., Schouls L. M., et al. Detection of Borrelia afzelii, Borrelia burgdorferi sensu stricto, Borrelia garinii and group VS116 by PCR in skin biopsies of patients with erythema migrans and acrodermatitis chronica atrophicans. Clin Microbiol Infect 1997; 3: 109–16
   PubMedGoogle Scholar
• Wang G., van Dam A. P., Dankert J. Phenotypic and genetic characterization of a novel Borrelia burgdorferi sensu lato isolate from a patient with lyme borreliosis. J Clin Microbiol 1999; 37: 3025–8
   PubMed Web of Science ®Google Scholar
• Wilske B. Diagnosis of lyme borreliosis in europe. Vector Borne Zoonotic Dis 2003; 3: 215–27
   PubMed Web of Science ®Google Scholar
• Liang F. T., Philipp M. T. Analysis of antibody response to invariable regions of VlsE, the variable surface antigen of Borrelia burgdorferi. Infect Immun 1999; 67: 6702–6
   PubMed Web of Science ®Google Scholar
• Liang F. T., Aberer E., Cinco M., Gern L., Hu C. M., Lobet Y. N., et al. Antigenic conservation of an immunodominant invariable region of the VlsE lipoprotein among European pathogenic genospecies of Borrelia burgdorferi SL. J Infect Dis 2000; 182: 1455–62
   PubMed Web of Science ®Google Scholar
• Mathiesen M. J., Christiansen M., Hansen K., Holm A., Asbrink E., Theisen M. Peptide‐based OspC enzyme‐linked immunosorbent assay for serodiagnosis of Lyme borreliosis. J Clin Microbiol 1998; 36: 3474–9
   PubMed Web of Science ®Google Scholar
• Wilske B., Schriefer M. Borrelia. Manual of Clinical Microbiology., P. R Murray, E. J Baron, J. H Jorgensen, M. A Pfaller, R. H Yolken, editors. ASM Press, Washington, D.C. 2003; 8th edition Volume 1: p. 937–54, In
   Google Scholar
• Aguero‐Rosenfeld M. E., Wang G., Schwartz I., Wormser G. P. Diagnosis of lyme borreliosis. Clin Microbiol Rev 2005; 18: 484–509
   PubMed Web of Science ®Google Scholar
• Wilske B., Zöller L., Brade V., Eiffert H., Göbel U. B., Stanek G., . MIQ 12, Lyme‐Borreliose. Qualitätsstandards in der mikrobiologisch‐ infektiologischen Diagnostik., H Mauch, R Lütticken, editors, et al. Urban & Fischer Verlag, MunichGermany 2000; p. 1–59, In
   Google Scholar
• Kaiser R. [Prevention of early summer meningoencephalitis and Lyme borreliosis before and after tick bites]. Dtsch Med Wochenschr 1998; 123: 847–53
   PubMedGoogle Scholar
• Preac‐Mursic V., Wilske B., Reinhardt S. Culture of Borrelia burgdorferi on six solid media. Eur J Clin Microbiol Infect Dis 1991; 10: 1076–9
   PubMed Web of Science ®Google Scholar
• Preac‐Mursic V., Wilske B., Schierz G. European Borrelia burgdorferi isolated from humans and ticks culture conditions and antibiotic susceptibility. Zentralbl Bakteriol Mikrobiol Hyg [A] 1986; 263: 112–8
   PubMedGoogle Scholar
• Arnez M., Ruzic‐Sabljic E., Ahcan J., Radsel‐Medvescek A., Pleterski‐Rigler D., Strle F. Isolation of Borrelia burgdorferi sensu lato from blood of children with solitary erythema migrans. Pediatr Infect Dis J 2001; 20: 251–5
   PubMed Web of Science ®Google Scholar
• Karlsson M., Hovind‐Hougen K., Svenungsson B., Stiernstedt G. Cultivation and characterization of spirochetes from cerebrospinal fluid of patients with Lyme borreliosis. J Clin Microbiol 1990; 28: 473–9
   PubMed Web of Science ®Google Scholar
• Strle F. Principles of the diagnosis and antibiotic treatment of Lyme borreliosis. Wien Klin Wochenschr 1999; 111: 911–5
   PubMed Web of Science ®Google Scholar
• Zore A., Ruzic‐Sabljic E., Maraspin V., Cimperman J., Lotric‐Furlan S., Pikelj A., et al. Sensitivity of culture and polymerase chain reaction for the etiologic diagnosis of erythema migrans. Wien Klin Wochenschr 2002; 114: 606–9
   PubMed Web of Science ®Google Scholar
• Wormser G. P., Bittker S., Cooper D., Nowakowski J., Nadelman R. B., Pavia C. Yield of large‐volume blood cultures in patients with early Lyme disease. J Infect Dis 2001; 184: 1070–2
   PubMed Web of Science ®Google Scholar
• Schmidt B. L. PCR in laboratory diagnosis of human Borrelia burgdorferi infections. Clin Microbiol Rev 1997; 10: 185–201
   PubMed Web of Science ®Google Scholar
• Aguero‐Rosenfeld M. E., Wang G., Schwartz I., Wormser G. P. Diagnosis of lyme borreliosis. Clin Microbiol Rev 2005; 18: 484–509
   PubMed Web of Science ®Google Scholar
• Asbrink E., Olsson I. Clinical manifestations of erythema chronicum migrans Afzelius in 161 patients. A comparison with Lyme disease. Acta Derm Venereol 1985; 65: 43–52
   PubMed Web of Science ®Google Scholar
• von Stedingk L. V., Olsson I., Hanson H. S., Asbrink E., Hovmark A. Polymerase chain reaction for detection of Borrelia burgdorferi DNA in skin lesions of early and late Lyme borreliosis. Eur J Clin Microbiol Infect Dis 1995; 14: 1–5
   PubMed Web of Science ®Google Scholar
• Wilske B., Preac‐Mursic V. Microbiological diagnosis of Lyme borreliosis. Aspects of Lyme Borreliosis., K Weber, W Burgdorfer, editors. Springer Verlag, Berlin, Heidelberg, Germany and New YorkUSA 1993; p. 267–300, In
   Google Scholar
• Lebech A. M., Hansen K., Brandrup F., Clemmensen O., Halkier‐Sorensen L. Diagnostic value of PCR for detection of Borrelia burgdorferi DNA in clinical specimens from patients with erythema migrans and Lyme neuroborreliosis. Mol Diagn 2000; 5: 139–50
   PubMedGoogle Scholar
• Nocton J. J., Dressler F., Rutledge B. J., Rys P. N., Persing D. H., Steere A. C. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis. N Engl J Med 1994; 330: 229–34
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease., MMWR Morb Mortal Wkly Rep. 44. 590
   Google Scholar
• Johnson B. J., Robbins K. E., Bailey R. E., Cao B. L., Sviat S. L., Craven R. B., et al. Serodiagnosis of Lyme disease: accuracy of a two‐step approach using a flagella‐based ELISA and immunoblotting. J Infect Dis 1996; 174: 346–53
   PubMed Web of Science ®Google Scholar
• Wilske B., Fingerle V., Herzer P., Hofmann A., Lehnert G., Peters H., et al. Recombinant immunoblot in the serodiagnosis of Lyme borreliosis. Comparison with indirect immunofluorescence and enzyme‐linked immunosorbent assay. Med Microbiol Immunol (Berl) 1993; 182: 255–70
   PubMed Web of Science ®Google Scholar
• Hansen K., Hindersson P., Pedersen N. S. Measurement of antibodies to the Borrelia burgdorferi flagellum improves serodiagnosis in Lyme disease. J Clin Microbiol 1988; 26: 338–46
   PubMed Web of Science ®Google Scholar
• Bacon R. M., Biggerstaff B. J., Schriefer M. E., Gilmore R. D., Jr., Philipp M. T., Steere A. C., et al. Serodiagnosis of Lyme disease by kinetic enzyme‐linked immunosorbent assay using recombinant VlsE1 or peptide antigens of Borrelia burgdorferi compared with 2‐tiered testing using whole‐cell lysates. J Infect Dis 2003; 187: 1187–99
   PubMed Web of Science ®Google Scholar
• Lawrenz M. B., Hardham J. M., Owens R. T., Nowakowski J., Steere A. C., Wormser G. P., et al. Human antibody responses to VlsE antigenic variation protein of Borrelia burgdorferi. J Clin Microbiol 1999; 37: 3997–4004
   PubMed Web of Science ®Google Scholar
• Liang F. T., Steere A. C., Marques A. R., Johnson B. J., Miller J. N., Philipp M. T. Sensitive and specific serodiagnosis of Lyme disease by enzyme‐linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi vlsE. J Clin Microbiol 1999; 37: 3990–6
   PubMed Web of Science ®Google Scholar
• Panelius J., Lahdenne P., Saxen H., Carlsson S. A., Heikkila T., Peltomaa M., et al. Diagnosis of Lyme neuroborreliosis with antibodies to recombinant proteins DbpA, BBK32, and OspC, and VlsE IR6 peptide. J Neurol 2003; 250: 1318–27
   PubMed Web of Science ®Google Scholar
• Heikkila T., Seppala I., Saxen H., Panelius J., Yrjanainen H., Lahdenne P. Species‐specific serodiagnosis of Lyme arthritis and neuroborreliosis due to Borrelia burgdorferi sensu stricto, B. afzelii, and B. garinii by using decorin binding protein A. J Clin Microbiol 2002; 40: 453–60
   PubMed Web of Science ®Google Scholar
• Hauser U., Lehnert G., Lobentanzer R., Wilske B. Interpretation criteria for standardized Western blots for three European species of Borrelia burgdorferi sensu lato. J Clin Microbiol 1997; 35: 1433–44
   PubMed Web of Science ®Google Scholar
• Hauser U., Lehnert G., Wilske B. Diagnostic value of proteins of three Borrelia species (Borrelia burgdorferi sensu lato) and implications for development and use of recombinant antigens for serodiagnosis of Lyme borreliosis in Europe. Clin Diagn Lab Immunol 1998; 5: 456–62
   PubMedGoogle Scholar
• Robertson J., Guy E., Andrews N., Wilske B., Anda P., Granström M., et al. A European multicenter study of immunoblotting in serodiagnosis of Lyme borreliosis. J Clin Microbiol 2000; 38: 2097–102
   PubMed Web of Science ®Google Scholar
• Dressler F., Ackermann R., Steere A. C. Antibody responses to the three genomic groups of Borrelia burgdorferi in European Lyme borreliosis. J Infect Dis 1994; 169: 313–8
   PubMed Web of Science ®Google Scholar
• Schulte‐Spechtel U., Lehnert G., Liegl G., Fingerle V., Heimerl C., Johnson B. J., et al. Significant improvement of the recombinant Borrelia‐specific immunoglobulin G immunoblot test by addition of VlsE and a DbpA homologue derived from Borrelia garinii for diagnosis of early neuroborreliosis. J Clin Microbiol 2003; 41: 1299–303
   PubMed Web of Science ®Google Scholar
• Wilske B., Habermann C., Fingerle V., Hillenbrand B., Jauris‐Heipke S., Lehnert G., et al. An improved recombinant IgG immunoblot for serodiagnosis of Lyme borreliosis. Med Microbiol Immunol (Berl) 1999; 188: 139–44
   PubMed Web of Science ®Google Scholar
• Goettner G., Schulte‐Spechtel U., Hillermann R., Liegl G., Wilske B., Fingerle V. Improvement of Lyme borreliosis serodiagnosis by a newly developed recombinant immunoglobulin G (IgG) and IgM line immunoblot assay and addition of VlsE and DbpA homologues. J Clin Microbiol 2005; 43: 3602–9
   PubMed Web of Science ®Google Scholar
• Schulte‐Spechtel U., Fingerle V., Goettner G., Rogge S., Wilske B. Molecular analysis of decorin binding protein A (DbpA) reveals five major groups among European Borrelia burgdorferi sensu lato strains with impact for the development of serological assays and indicates lateral gene transfer of the dbpA gene. Int J Med Microbiol 2005, In press
   Web of Science ®Google Scholar
• Wilske B., Schierz G., Preac‐Mursic V., von Busch K., Kuhbeck R., Pfister H. W., et al. Intrathecal production of specific antibodies against Borrelia burgdorferi in patients with lymphocytic meningoradiculitis (Bannwarth's syndrome). J Infect Dis 1986; 153: 304–14
   PubMed Web of Science ®Google Scholar
• Hansen K., Cruz M., Link H. Oligoclonal Borrelia burgdorferi‐specific IgG antibodies in cerebrospinal fluid in Lyme neuroborreliosis. J Infect Dis 1990; 161: 1194–202
   PubMed Web of Science ®Google Scholar
• Hansen K., Lebech A. M. Lyme neuroborreliosis: a new sensitive diagnostic assay for intrathecal synthesis of Borrelia burgdorferi‐specific immunoglobulin G, A, and M. Ann Neurol 1991; 30: 197–205
   PubMed Web of Science ®Google Scholar
• Christen H. J., Hanefeld F., Eiffert H., Thomssen R. Epidemiology and clinical manifestations of Lyme borreliosis in childhood. A prospective multicentre study with special regard to neuroborreliosis. Acta Paediatr Suppl 1993; 386: 1–75
   PubMedGoogle Scholar
• Stanek G., O'Connell S., Cimmino M., Aberer E., Kristoferitsch W., Granstrom M., et al. European Union Concerted Action on Risk Assessment in Lyme Borreliosis: clinical case definitions for Lyme borreliosis. Wien Klin Wochenschr 1996; 108: 741–7
   PubMed Web of Science ®Google Scholar
• Kristoferitsch W. Neurologic manifestations in Lyme borreliosis. Clin Dermatol 1993; 11: 393–400
   PubMed Web of Science ®Google Scholar
• Asbrink E., Hovmark A., Hederstedt B. Serologic studies of erythema chronicum migrans Afzelius and acrodermatitis chronica atrophicans with indirect immunofluorescence and enzyme‐linked immunosorbent assays. Acta Derm Venereol 1985; 65: 509–14
   PubMed Web of Science ®Google Scholar
• Hansen K., Asbrink E. Serodiagnosis of erythema migrans and acrodermatitis chronica atrophicans by the Borrelia burgdorferi flagellum enzyme‐linked immunosorbent assay. J Clin Microbiol 1989; 27: 545–51
   PubMed Web of Science ®Google Scholar
• Lahdenne P., Panelius J., Saxen H., Heikkila T., Sillanpaa H., Peltomaa M., et al. Improved serodiagnosis of erythema migrans using novel recombinant borrelial BBK32 antigens. J Med Microbiol 2003; 52: 563–7
   PubMed Web of Science ®Google Scholar
• Philipp M. T., Wormser G. P., Marques A. R., Bittker S., Martin D. S., Nowakowski J., et al. A decline in c6 antibody titer occurs in successfully treated patients with culture‐confirmed early localized or early disseminated Lyme borreliosis. Clin Diagn Lab Immunol 2005; 12: 1069–74
   PubMedGoogle Scholar
• Peltomaa M., McHugh G., Steere A. C. Persistence of the antibody response to the VlsE sixth invariant region (IR6) peptide of Borrelia burgdorferi after successful antibiotic treatment of Lyme disease. J Infect Dis 2003; 187: 1178–86
   PubMed Web of Science ®Google Scholar
• Department of Health and Human Services CfDCaP. Caution regarding testing for Lyme disease., MMWR Morb Mortal Wkly Rep. 54. 125
   Google Scholar
• Buechner S. A., Lautenschlager S., Itin P., Bircher A., Erb P. Lymphoproliferative responses to Borrelia burgdorferi in patients with erythema migrans, acrodermatitis chronica atrophicans, lymphadenosis benigna cutis, and morphea. Arch Dermatol 1995; 131: 673–7
   PubMedGoogle Scholar
• Dattwyler R. J., Volkman D. J., Luft B. J., Halperin J. J., Thomas J., Golightly M. G. Seronegative Lyme disease. Dissociation of specific T‐ and B‐lymphocyte responses to Borrelia burgdorferi. N Engl J Med 1988; 319: 1441–6
   PubMed Web of Science ®Google Scholar
• Kalish R. S., Wood J. A., Golde W., Bernard R., Davis L. E., Grimson R. C., et al. Human T lymphocyte response to Borrelia burgdorferi infection: no correlation between human leukocyte function antigen type 1 peptide response and clinical status. J Infect Dis 2003; 187: 102–8
   PubMed Web of Science ®Google Scholar
• Horowitz H. W., Pavia C. S., Bittker S., Forseter G., Cooper D., Nadelman R. B., et al. Sustained cellular immune responses to Borrelia burgdorferi: lack of correlation with clinical presentation and serology. Clin Diagn Lab Immunol 1994; 1: 373–8
   PubMedGoogle Scholar
• Coyle P. K., Schutzer S. E., Belman A. L., Krupp L. B., Dheng Z. Cerebrospinal fluid immunologic parameters in neurologic Lyme disease. Lyme disease: Molecular and immunologic approaches., S. E Schutzer, editor. Cold Spring Harbor Laboratory Press, New YorkUSA 1992; p. 31–44, In
   Google Scholar
• Hyde F. W., Johnson R. C., White T. J., Shelburne C. E. Detection of antigens in urine of mice and humans infected with Borrelia burgdorferi, etiologic agent of Lyme disease. J Clin Microbiol 1989; 27: 58–61
   PubMed Web of Science ®Google Scholar
• Klempner M. S., Schmid C. H., Hu L., Steere A. C., Johnson G., McCloud B., et al. Intralaboratory reliability of serologic and urine testing for Lyme disease. Am J Med 2001; 110: 217–9
   PubMed Web of Science ®Google Scholar
• Brettschneider S., Bruckbauer H., Klugbauer N., Hofmann H. Diagnostic value of PCR for detection of Borrelia burgdorferi in skin biopsy and urine samples from patients with skin borreliosis. J Clin Microbiol 1998; 36: 2658–65
   PubMed Web of Science ®Google Scholar
• Karch H., Huppertz H. I., Bohme M., Schmidt H., Wiebecke D., Schwarzkopf A. Demonstration of Borrelia burgdorferi DNA in urine samples from healthy humans whose sera contain B. burgdorferi‐specific antibodies. J Clin Microbiol 1994; 32: 2312–4
   PubMed Web of Science ®Google Scholar
• Richter D., Schlee D. B., Allgower R., Matuschka F. R. Relationships of a novel Lyme disease spirochete, Borrelia spielmani sp. nov., with its hosts in Central Europe. Appl Environ Microbiol 2004; 70: 6414–9
   PubMed Web of Science ®Google Scholar
• Wilske B., Busch U., Fingerle V., Jauris‐Heipke S., Preac M., V., Rössler D., et al. Immunological and molecular variability of OspA and OspC. Implications for Borrelia vaccine development. Infection 1996; 24: 208–12
   PubMed Web of Science ®Google Scholar
• Wilske B. Microbiological diagnosis in Lyme borreliosis. Int J Med Microbiol 2002; 291((Suppl 33))114–9
   PubMedGoogle Scholar